NETRAMARK TO ATTEND AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONFERENCE IN CHICAGO
June 1, 2023
Healthcare Providers & Services
-
-
NETRAMARK TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, MAY 31, AND WEDNESDAY, JUNE 7, 2023
May 30, 2023
-
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
May 24, 2023
-
ByoPlanet and Merck Animal Health Announce Partnership with USEF
May 23, 2023
-
BIMI International Medical Inc. Announces First Quarter 2023 Financial Results
May 22, 2023
-
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
May 18, 2023
-
NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKING TECHNOLOGY THAT INTEGRATES CHATGPT
May 16, 2023
-
QHSLab, Inc. Reports First Quarter Financial Results
May 15, 2023
-
OptimizeRx to Participate in Upcoming Investor Conferences
May 15, 2023
-
NETRAMARK REVEALS INSIGHTS FOR LUNG CANCER TRIALS IN PEER REVIEWED PUBLICATION
May 10, 2023
-
Netramark Engages ITG as Market Maker to Enhance Trading Liquidity
May 9, 2023
-
PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)
May 9, 2023
-
Bitech Technologies Receives Letter of Intent for up to $300 Million to Invest in Solar and Battery Energy Storage System Projects
May 8, 2023
-
Netramark Successfully Delivers on Biopharma Client Contract
May 2, 2023
-
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
May 2, 2023
-
PUR Biologics Expands Sales Network by 15%, Adding 32 New Distributors
April 27, 2023